NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Insmed Incorporated (NASDAQ: INSM)
INSM Technical Analysis
4
As on 9th Jun 2023 INSM STOCK Price closed @ 19.80 and we RECOMMEND Sell for LONG-TERM with Stoploss of 22.38 & Strong Sell for SHORT-TERM with Stoploss of 24.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INSMSTOCK Price
Open | 20.11 | Change | Price | % |
High | 20.11 | 1 Day | -0.23 | -1.15 |
Low | 19.64 | 1 Week | 0.77 | 4.05 |
Close | 19.80 | 1 Month | 0.55 | 2.86 |
Volume | 513848 | 1 Year | -8.55 | -30.16 |
52 Week High 28.42 | 52 Week Low 16.26 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
INSM Daily Charts |
INSM Intraday Charts |
Whats New @ Bazaartrend |
INSM Free Analysis |
|
INSM Important Levels Intraday
RESISTANCE | 20.71 |
RESISTANCE | 20.42 |
RESISTANCE | 20.24 |
RESISTANCE | 20.06 |
SUPPORT | 19.54 |
SUPPORT | 19.36 |
SUPPORT | 19.18 |
SUPPORT | 18.89 |
INSM Forecast April 2024
4th UP Forecast | 33.02 |
3rd UP Forecast | 28.78 |
2nd UP Forecast | 26.16 |
1st UP Forecast | 23.54 |
1st DOWN Forecast | 16.06 |
2nd DOWN Forecast | 13.44 |
3rd DOWN Forecast | 10.82 |
4th DOWN Forecast | 6.58 |
INSM Weekly Forecast
4th UP Forecast | 23.60 |
3rd UP Forecast | 22.38 |
2nd UP Forecast | 21.63 |
1st UP Forecast | 20.87 |
1st DOWN Forecast | 18.73 |
2nd DOWN Forecast | 17.97 |
3rd DOWN Forecast | 17.22 |
4th DOWN Forecast | 16.00 |
INSM Forecast2024
4th UP Forecast | 44.66 |
3rd UP Forecast | 36.69 |
2nd UP Forecast | 31.76 |
1st UP Forecast | 26.83 |
1st DOWN Forecast | 12.77 |
2nd DOWN Forecast | 7.84 |
3rd DOWN Forecast | 2.91 |
4th DOWN Forecast | -5.06 |
Insmed Incorporated ( NASDAQ USA Symbol : INSM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INSM Other Details
Segment | EQ | |
Market Capital | 3410158848.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
INSM Address
INSM Latest News
INSM Business Profile
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807-1704
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service